CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Neurological Examinationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03250988
NCT03250988N/ACompleted
CompareCT.gov

Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility

Vanderbilt University Medical Center·observational·Posted Aug 16, 2017·Updated Oct 9, 2018

In Brief

An observational study evaluating Neurological Examination for Spasticity, Muscle and 8 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this study is to improve spasticity diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSpasticity, Muscle, Muscular Diseases, Musculoskeletal Disease, Muscle Hypertonia, Muscle Spasticity, Neuromuscular Manifestations, Signs and Symptoms, Nervous System Diseases, Neurologic Manifestations
CountriesUnited States
CollaboratorsAllergan

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 16, 2017
Enrollment StartJan 30, 2018
Primary CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.9 years ago

Interventions

Neurological Examinationother

The subject will undergo elements of the neurological examination during which the movement disorders neurologist will look specifically for the presence of spasticity. If spasticity is found to be present during the examination, the neurologist will rate the severity of the spasticity in all affected limbs and record whether they would recommend treatment for spasticity, and if so, which treatment(s) they believe would be beneficial for the subject.